Author
Harvard University
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
2 papers
Recent·Most cited
Alex C.Y. Chen, Keely Y. Ji, Cansu Yerinde…·Debattama R. Sen
This study identifies Dusp5 and Zfp219 as key regulators of age-related T cell dysfunction using CRISPR screens and shows their potential as therapeutic targets.
Avanish Mishra, Rachel O. Abelman, Quinn E. Cunneely…·Shyamala Maheswaran
In metastatic breast cancer on TROP2- or HER2-targeting antibody-drug conjugates, early CTC disappearance or steep decline tracked response, while CTC epitope levels neither predicted benefit nor vanished at resistance.